HK Stock MarketDetailed Quotes

JW THERAP-B (02126)

Watchlist
  • 2.620
  • +0.140+5.65%
Trading May 7 10:27 CST
1.09BMarket Cap-1.78P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JW THERAP-B (02126) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
出售自体嵌合抗原受体T细胞免疫治疗产品所得收入218.96M77.19%
非独家许可授权收入64.47M22.73%
Other217K0.08%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
倍诺达218.96M77.19%
非独家许可授权64.47M22.73%
Other217K0.08%

By Country/Region

No Data

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.53%
Sample Name
Sample Code
 +3.68%
Sample Name
Sample Code
 +1.09%
4
SHANGHAI PECHEM
00338
+0.78%
5
SINOPEC CORP
00386
0.00%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +65.68%
Sample Name
Sample Code
 +58.80%
Sample Name
Sample Code
 +44.01%
4
Loongson Technology Corporation
688047
+43.17%
5
Digital China Group
000034
+25.89%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -